Elumalai K

Title : Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application - Jayaprakash_2025_Chronic.Dis.Transl.Med_11_105

Author(s) : Jayaprakash N , Elumalai K

Ref : Chronic Dis Transl Med , 11 :105 , 2025

Abstract :

PubMedSearch : Jayaprakash_2025_Chronic.Dis.Transl.Med_11_105

PubMedID: 40486952

Title : AChE inhibitor: a regio- and stereo-selective 1,3-dipolar cycloaddition for the synthesis of novel substituted 5,6-dimethoxy spiro[5.3']-oxindole-spiro-[6.3'']-2,3-dihydro-1H-inden-1''-one-7-(substituted aryl)-tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazole - Ashraf_2012_Bioorg.Med.Chem.Lett_22_508

Author(s) : Ashraf Ali M , Ismail R , Choon TS , Kumar RS , Osman H , Arumugam N , Almansour AI , Elumalai K , Singh A

Ref : Bioorganic & Medicinal Chemistry Lett , 22 :508 , 2012

Abstract :

PubMedSearch : Ashraf_2012_Bioorg.Med.Chem.Lett_22_508

PubMedID: 22142546

Elumalai K

References (2)

1. Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application - Jayaprakash_2025_Chronic.Dis.Transl.Med_11_105

2. AChE inhibitor: a regio- and stereo-selective 1,3-dipolar cycloaddition for the synthesis of novel substituted 5,6-dimethoxy spiro[5.3']-oxindole-spiro-[6.3'']-2,3-dihydro-1H-inden-1''-one-7-(substituted aryl)-tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazole - Ashraf_2012_Bioorg.Med.Chem.Lett_22_508